Nowak Medecine: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Nowak Medecine
Largest movements
- Cash +€85,024
up €85,024 (+6,112%), from €1,391 to €86,415
mainly Net result for the year (+€74,486) and Tax, wage and social debts (+€10,594)
- Deferred charges and accrued income +€4,125
up €4,125 (+41.8%), from €9,880 to €14,005
- Tangible fixed assets +€2,298
up €2,298 (+169%), from €1,361 to €3,659
of which Plant, machinery and equipment: +€2,794
- Reserves +€74,486
up €74,486 (+4,173%), from €1,785 to €76,271
- Tax, wage and social debts +€10,594
up €10,594 (+327%), from €3,241 to €13,835
of which Taxes: +€9,694
- Trade debts +€3,426
up €3,426 (+88.9%), from €3,852 to €7,278
- Other debts +€2,940
up €2,940 (+235%), from €1,254 to €4,194
- Gross operating margin +€92,371
up €92,371 (+3,732%), from €2,475 to €94,846
- Taxes +€18,761
up €18,761 (+3,324%), from €564 to €19,326
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,632 | €104,078 | +€91,447 | +724% |
| Fixed assets | 21/28 | €1,361 | €3,659 | +€2,298 | +169% |
| Tangible fixed assets | 22/27 | €1,361 | €3,659 | +€2,298 | +169% |
| Plant, machinery and equipment | 23 | - | €2,794 | +€2,794 | |
| Furniture and vehicles | 24 | €1,361 | €865 | -€496 | -36.4% |
| Current assets | 29/58 | €11,271 | €100,419 | +€89,149 | +791% |
| Cash at bank and in hand | 54/58 | €1,391 | €86,415 | +€85,024 | +6,112% |
| Deferred charges and accrued income | 490/1 | €9,880 | €14,005 | +€4,125 | +41.8% |
| Total equity and liabilities | 10/49 | €12,632 | €104,078 | +€91,447 | +724% |
| Equity | 10/15 | €4,285 | €78,771 | +€74,486 | +1,738% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €1,785 | €76,271 | +€74,486 | +4,173% |
| Distributable reserves | 133 | €1,785 | €76,271 | +€74,486 | +4,173% |
| Amounts payable | 17/49 | €8,346 | €25,307 | +€16,960 | +203% |
| Amounts payable within one year | 42/48 | €8,346 | €25,307 | +€16,960 | +203% |
| Trade debts | 44 | €3,852 | €7,278 | +€3,426 | +88.9% |
| Suppliers | 440/4 | €3,852 | €7,278 | +€3,426 | +88.9% |
| Taxes, remuneration and social security | 45 | €3,241 | €13,835 | +€10,594 | +327% |
| Taxes | 450/3 | €2,041 | €11,735 | +€9,694 | +475% |
| Remuneration and social security | 454/9 | €1,200 | €2,100 | +€900 | +75.0% |
| Other amounts payable | 47/48 | €1,254 | €4,194 | +€2,940 | +235% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €126 | €533 | +€407 | +323% |
| Gross operating margin | 9900 | €2,475 | €94,846 | +€92,371 | +3,732% |
| Operating profit (loss) | 9901 | €2,349 | €94,313 | +€91,964 | +3,915% |
| Financial income | 75/76B | €0 | €3 | +€3 | +770% |
| Recurring financial income | 75 | €0 | €3 | +€3 | +770% |
| Financial charges | 65/66B | - | €504 | +€504 | |
| Recurring financial charges | 65 | - | €504 | +€504 | |
| Profit (loss) for the period before taxes | 9903 | €2,349 | €93,812 | +€91,463 | +3,893% |
| Income taxes | 67/77 | €564 | €19,326 | +€18,761 | +3,324% |
| Profit (loss) for the period | 9904 | €1,785 | €74,486 | +€72,701 | +4,073% |
| Profit (loss) for the period to be appropriated | 9905 | €1,785 | €74,486 | +€72,701 | +4,073% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.